AIMC Topic: Glucagon-Like Peptides

Clear Filters Showing 1 to 1 of 1 articles

Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis.

Hepatology (Baltimore, Md.)
BACKGROUND AND AIMS: Artificial intelligence-powered digital pathology offers the potential to quantify histological findings in a reproducible way. This analysis compares the evaluation of histological features of NASH between pathologists and a mac...